Hsieh CY - Search Results

1

Retraction: Knockdown of Contactin-1 Expression Suppresses Invasion and Metastasis of Lung Adenocarcinoma.

Su JL, Yang CY, Shih JY, Wei LH, Hsieh CY, Jeng YM, Wang MY, Yang PC, Kuo ML. Su JL, et al. Among authors: hsieh cy. Cancer Res. 2019 Jul 15;79(14):3793. doi: 10.1158/0008-5472.CAN-19-1711. Cancer Res. 2019. PMID: 31308141 No abstract available.

2

Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma.

Su JL, Shih JY, Yen ML, Jeng YM, Chang CC, Hsieh CY, Wei LH, Yang PC, Kuo ML. Su JL, et al. Among authors: hsieh cy. Cancer Res. 2004 Jan 15;64(2):554-64. doi: 10.1158/0008-5472.can-03-1301. Cancer Res. 2004. PMID: 14744769

3

Knockdown of contactin-1 expression suppresses invasion and metastasis of lung adenocarcinoma.

Su JL, Yang CY, Shih JY, Wei LH, Hsieh CY, Jeng YM, Wang MY, Yang PC, Kuo ML. Su JL, et al. Among authors: hsieh cy. Cancer Res. 2006 Mar 1;66(5):2553-61. doi: 10.1158/0008-5472.CAN-05-2645. Cancer Res. 2006. Retraction in: Cancer Res. 2019 Jul 15;79(14):3793. doi: 10.1158/0008-5472.CAN-19-1711 PMID: 16510572 Retracted.

4

A novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth.

Su JL, Lai KP, Chen CA, Yang CY, Chen PS, Chang CC, Chou CH, Hu CL, Kuo ML, Hsieh CY, Wei LH. Su JL, et al. Among authors: hsieh cy. Cancer Res. 2005 Jun 1;65(11):4827-35. doi: 10.1158/0008-5472.CAN-05-0188. Cancer Res. 2005. PMID: 15930303

5

The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells.

Su JL, Yang PC, Shih JY, Yang CY, Wei LH, Hsieh CY, Chou CH, Jeng YM, Wang MY, Chang KJ, Hung MC, Kuo ML. Su JL, et al. Among authors: hsieh cy. Cancer Cell. 2006 Mar;9(3):209-23. doi: 10.1016/j.ccr.2006.02.018. Cancer Cell. 2006. PMID: 16530705 Free article.

6

Editor's Note: A Novel Peptide Specifically Binding to Interleukin-6 Receptor (gp80) Inhibits Angiogenesis and Tumor Growth.

Su JL, Lai KP, Chen CA, Yang CY, Chen PS, Chang CC, Chou CH, Hu CL, Kuo ML, Hsieh CY, Wei LH. Su JL, et al. Among authors: hsieh cy. Cancer Res. 2019 Jul 15;79(14):3791. doi: 10.1158/0008-5472.CAN-19-1712. Cancer Res. 2019. PMID: 31308139 No abstract available.

7

Overexpression of Her-2/NEU in epithelial ovarian carcinoma induces vascular endothelial growth factor C by activating NF-kappa B: implications for malignant ascites formation and tumor lymphangiogenesis.

Hsieh CY, Chen CA, Chou CH, Lai KP, Jeng YM, Kuo ML, Wei LH. Hsieh CY, et al. J Biomed Sci. 2004 Mar-Apr;11(2):249-59. doi: 10.1007/BF02256568. J Biomed Sci. 2004. PMID: 14966375

8

Pre-clinical and early-phase clinical studies of curcumin as chemopreventive agent for endemic cancers in Taiwan.

Hsu CH, Chuang SE, Hergenhahn M, Kuo ML, Lin JK, Hsieh CY, Cheng AL. Hsu CH, et al. Among authors: hsieh cy. Gan To Kagaku Ryoho. 2002 Feb;29 Suppl 1:194-200. Gan To Kagaku Ryoho. 2002. PMID: 11890105 No abstract available.

9

Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway.

Wei LH, Kuo ML, Chen CA, Chou CH, Lai KB, Lee CN, Hsieh CY. Wei LH, et al. Among authors: hsieh cy. Oncogene. 2003 Mar 13;22(10):1517-27. doi: 10.1038/sj.onc.1206226. Oncogene. 2003. PMID: 12629515

10

Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-kappaB pathway by lysophosphatidic acid, an ovarian cancer-activating factor.

Chou CH, Wei LH, Kuo ML, Huang YJ, Lai KP, Chen CA, Hsieh CY. Chou CH, et al. Among authors: hsieh cy. Carcinogenesis. 2005 Jan;26(1):45-52. doi: 10.1093/carcin/bgh301. Epub 2004 Oct 7. Carcinogenesis. 2005. PMID: 15471896

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

922 results

Search Page

Filters